Guest: Sherwin Charles – CEO GoodBye Malaria and Global fund board member

For two decades, the Global Fund has called on the world to commit to defeating HIV, TB, and malaria, end health inequity, and protect humanity from pandemics by raising money in three-year cycles known as Replenishments. On the 21st September, The United States of America-hosted pledging conference for the Global Fund to Fight AIDS, Tuberculosis and Malaria raised more than US$14.25 billion – the organisation’s most significant pledging commitment to date. This contribution will be

invested strategically in programmes to build resilient and sustainable systems for health and strengthen pandemic preparedness for vulnerable, malaria-endemic regions like Southern Africa. “The last two years have demonstrated how old and new pandemics interact and how catastrophic this combination can be for those most affected by HIV, TB, and malaria. However, ending malaria is definitely in sight; we have the people, we have the tools, and with the Global Fund, we have the resources. So, ensuring we had a successful replenishment was not negotiable,” says Sherwin Charles, co-founder and CEO of Goodbye Malaria who joins us on the line… - Who are the beneficiaries (Locally) - What percentage did GBM receive - Mosquirix roll out and affordability? Possible production in Eastern Cape?? - Corporate parentship